| Patents for A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316) |
|---|
| 05/20/2004 | US20040096484 Antioxidant-containing wipes and absorbent products for improving skin health |
| 05/20/2004 | US20040096479 Ultra-high fiber supplement and method of cancer reduction |
| 05/20/2004 | US20040096420 Compositions and methods for treating baldness |
| 05/20/2004 | US20040096419 Cosmetic preparation containing vitamin a |
| 05/20/2004 | US20040096418 Cosmetically effective composition containing malva sylvestris and mentha piperita extracts |
| 05/20/2004 | US20040096417 Moringa esters and cosmetic and pharmaceutical preparations and methods of manufacture thereof |
| 05/20/2004 | US20040094449 Melatonin daily dosage units |
| 05/19/2004 | EP1419781A1 Odontostomatological use of plant compounds based on rhubarb roots (species belonging to the Rheum genus) and spinach leaves (spinacia oleracea l.) |
| 05/19/2004 | EP1419780A1 Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of senile dementia and Alzheimer's disease |
| 05/19/2004 | EP1419768A1 Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| 05/19/2004 | EP1418929A2 Simmondsin processing methods and products |
| 05/19/2004 | EP1418889A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 05/19/2004 | EP1418869A1 Kavalactone compositions and methods of use |
| 05/19/2004 | EP1190716B1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
| 05/19/2004 | DE202004004618U1 Composition containing bilberry extract, useful for treating headache and migraine, also contains antioxidants and micronutrients |
| 05/19/2004 | DE10250412A1 Orally administered herbal hypoglycemic agent, useful for treating type II diabetes mellitus, comprising leaves or stems of Sorbus genus plants, preferably mountain ash |
| 05/19/2004 | CN1498084A Low glycemic response compositions |
| 05/19/2004 | CN1150010C Method for removing farm chemical ingredients from ginseng extract |
| 05/19/2004 | CN1149977C Pharmaceutical compositions in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 05/19/2004 | CN1149972C Composition for combating skin blemishes and/or ageing of skin, and uses thereof |
| 05/18/2004 | US6737442 Food compositions for reducing insulin resistance |
| 05/18/2004 | US6737441 Preventing or treating persistent chronic gastritis, ulcers and/or stomach cancer |
| 05/18/2004 | US6737089 From the indian mulberry plant. |
| 05/18/2004 | US6737087 Composition containing Asiasari Radix extracts for protecting brain cells and improving memory |
| 05/18/2004 | US6737086 For accelerating and amplifying the synthesis of thermal shock proteins of cells of living beings |
| 05/18/2004 | US6737085 Naturally derived antidepressant composition in the form of a food, dietary supplement, medicine or the like that contains neither hypericin nor hyperforin and is safer even during extended administration, for therapy of depression |
| 05/18/2004 | US6737084 Borage seed oil, angelica pubescens root, coleus forskohlii extract, vinpocetine, ferulic acid, magnesium, ascorbyl palmitate, capric/caprylic triglyceride, and silica; topical |
| 05/18/2004 | US6737068 Wipe formulation |
| 05/13/2004 | WO2004039454A1 Formulations containing melatonin, ginkgo biloba, and biotin |
| 05/13/2004 | WO2004039390A1 Ointment composition for treating decubitus ulcers and methods for its making and its use |
| 05/13/2004 | WO2004039389A1 SELECTIVE HUMAN β3 ADRENALIN RECEPTOR AGONIST AGENT |
| 05/13/2004 | WO2004039388A1 α-GLUCOSIDASE INHIBITOR |
| 05/13/2004 | WO2004039387A1 A process of manufacturing a heamostatic agent from typha elephantina for arresting bleeding and healing open cuts and wounds |
| 05/13/2004 | WO2004039386A1 Method for isolation of sylimarin from sylibum marianum seeds |
| 05/13/2004 | WO2004039385A2 Mucuna pruriens and extracts thereof for the treatment of neurological diseases |
| 05/13/2004 | WO2004039384A1 Sexual desire and performance enhancement with meal from plants containing protein-bound tryptophan |
| 05/13/2004 | WO2004039369A1 Daily melatonin dosing units |
| 05/13/2004 | WO2004039160A1 Method and composition for the prevention of the auto-oxidation of flavors and fragrances |
| 05/13/2004 | WO2004019960A3 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 05/13/2004 | WO2004000045A3 Liquid compositions comprising non-digestible oligosaccharides and green tea catechins, method and uses thereof |
| 05/13/2004 | WO2003101389A3 Relief of aids symptoms |
| 05/13/2004 | WO2003061572A3 Anti-inflammatory formulations |
| 05/13/2004 | WO2002062367A8 Medical composition for managing hormone balance |
| 05/13/2004 | WO2002047703A8 Immune system stimulation |
| 05/13/2004 | US20040093644 Recombinant subunit proteins from porcine parvovirus produced in plants |
| 05/13/2004 | US20040092580 Antitumor agents; anticancer agents |
| 05/13/2004 | US20040092458 Administering a Free-B-Ring flavonoid as cyclooxygenase-2 (COX-2) inhibitor to treat osteoarthritis, rheumatoid arthritis, menstrual cramps, Systemic Lupus Erythromatosis, psoriasis, migraines, inflammatory bowel disease, cancer |
| 05/13/2004 | US20040091559 Compositions for diabetes treatment and prophylaxis |
| 05/13/2004 | US20040091558 For killing, inhibiting the growth or microorganisms, preserving products |
| 05/13/2004 | US20040091557 Gloves; botanical extract, is incorporated into an elastomer emulsion, solution and/or plastisol in order to enhance the physical and therapeutic properties of articles made from these materials |
| 05/13/2004 | US20040091556 For topical application and saturation of portions of sinus physiology, for therapy of cold or flu |
| 05/13/2004 | US20040091555 Methods for producing agrimonia extracts with improved activity against hepatitis b virus and pharmaceutical and food compositions containing said extracts |
| 05/13/2004 | US20040091554 Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors |
| 05/13/2004 | US20040091520 Disposable gloves with at least one alpha hydroxy acid |
| 05/13/2004 | US20040091519 Disposable gloves with allatoin |
| 05/13/2004 | US20040091509 Skin care composition that mediates cell to cell communication |
| 05/13/2004 | US20040091504 A glove has a layer comprising natural rubber latex, or synthetic polyisoprene, with aloe vera plant extract, for comfort wearing, moisturizing, therapeutic purpose; condom, catheter, stent, incontinence device sheath |
| 05/13/2004 | US20040091493 Active ingredient such as specified plant extract(s) or calcium compound that does not cause any inflammatory, irritation or intolerance reactions; tissue models for drug screening for drugs against skin disorders; dandruff, acne |
| 05/13/2004 | US20040091477 Immunophilin-binding compound and ginkgolide compound |
| 05/13/2004 | US20040091449 Compositions for darkening the skin and/or hair |
| 05/13/2004 | US20040088901 Controlled released fish attractant applied to the fishing lure or natural bait |
| 05/13/2004 | DE4437725B4 Verwendung von Saccharomyces-Hefen für die Herstellung eines Arzneimittels gegen Kryptosporidiose Use of Saccharomyces yeasts for the manufacture of a medicament against cryptosporidiosis |
| 05/13/2004 | DE10251256A1 Transdermales Wirkstoffabgabesystem für Oxybutynin Transdermal drug delivery system for oxybutynin |
| 05/13/2004 | DE10250646A1 Cosmetic and/or pharmaceutical hair treatment compositions, especially for promoting hair growth, containing melatonin (or derivative) and Gingko biloba and biotin as potentiating agents |
| 05/13/2004 | CA2504361A1 Formulations containing melatonin, ginkgo biloba, and biotin |
| 05/13/2004 | CA2504341A1 Melatonin daily dosing units |
| 05/13/2004 | CA2504201A1 Mucuna pruriens and extracts thereof for the treatment of neurological diseases |
| 05/12/2004 | EP1417970A2 Anti-allergic, anti-bacteric and anti-redden compound for eyes |
| 05/12/2004 | EP1417966A1 Flavonol glycosides as neutralizing agent for clostridium bacterial neurotoxins and preparation method thereof |
| 05/12/2004 | EP1416966A2 Methods for treating joint inflammation, pain, and loss of mobility |
| 05/12/2004 | EP1416950A1 Artichoke leaf extracts |
| 05/12/2004 | EP1416949A1 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba |
| 05/12/2004 | EP1416948A1 Compositions for removal of toxins |
| 05/12/2004 | EP1416927A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect |
| 05/12/2004 | EP1416926A2 Zinc containing compositions for anti-viral use |
| 05/12/2004 | EP1303284A4 Compositions and methods for the treatment of skin damage |
| 05/12/2004 | EP1156810B1 Solution for injection for the treatment of arthroses |
| 05/12/2004 | EP1115818B1 Water-soluble concentrate obtained for an emulgator or water-solubilising phase and a complex of liquid lipophile substances of plant origin |
| 05/12/2004 | CN1496255A Inhibition of NF-KB by triterpene compositions |
| 05/12/2004 | CN1495250A Method for purifying tagetes oil-containing resin |
| 05/12/2004 | CN1494916A Chinese medicine composition for promoting bllod circulation and its preparation method |
| 05/12/2004 | CN1494910A Medicine containing pulsatilla root extuact as active component for curing solid tumor |
| 05/12/2004 | CN1494901A Yanming qingsong plaster and it preparation method |
| 05/12/2004 | CN1494886A Loal color-lightening compound and its application method |
| 05/12/2004 | CN1494885A Granulation method of raw medicine component preparation |
| 05/12/2004 | CN1149018C Method and equipment for destructive distillation of haw kernel to extract juice |
| 05/11/2004 | US6733802 Insecticidal emulsion in an essential oil and surface active agent; free of synthetic active agents, inert ingredients or long-lived or toxic organic solvents |
| 05/11/2004 | US6733801 Method of using fermented glycine max (L) extract for enhancing natural killer cell activity |
| 05/11/2004 | US6733800 Extract of glycyrrhiza glabra and picrorhiza kurroa |
| 05/11/2004 | US6733799 Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
| 05/11/2004 | US6733798 Mixture of sitrosterol and lecithin |
| 05/11/2004 | US6733797 Neuroceutical for improving memory and cognitive abilities |
| 05/11/2004 | US6733796 Saw palmetto extract provided in an oral controlled release formulation; maintenance of therapeutic levels of active agents in the bloodstream for prolonged periods of time. |
| 05/11/2004 | US6733795 Liquid-solid extraction step followed by evaporation under vacuum, then a heat treatment step; may be performed in the reverse order. |
| 05/11/2004 | US6733794 Topical composition for antiseptic and analgesic purposes |
| 05/06/2004 | WO2004037283A1 Bowman-birk inhibitor concentrate product and process |
| 05/06/2004 | WO2004037276A1 Method and composition for enhancing vascular function |
| 05/06/2004 | WO2004037184A2 Methods for the treatment of skin disorders |
| 05/06/2004 | WO2004037010A1 A feed supplement and use thereof for elevating levels of essential fatty acids in livestock and products therefrom |
| 05/06/2004 | WO2004037001A1 Food with lowered glycemic index |